ASCO GUIDELINES Bundle

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475492

Contents of this Issue

Navigation

Page 8 of 9

Table 3. The Talcott's Classification Group I Inpatients (at the time of fever onset) Group II Outpatients with acute comorbidity requiring by itself hospitalization Group III Outpatients without comorbidity but with uncontrolled cancer Group IV a Outpatients with cancer controlled and without comorbidity a Group IV is considered to be low risk. Table 4. The Clinical Index of Stable Febrile Neutropenia (CISNE) Includes Six Explanatory Variable Associated with Serious Complications a Explanatory variable Number of points Eastern Cooperative Oncolog y Group performance status ≥2 2 Chronic obstructive pulmonary disease 1 Chronic cardiovascular disease 1 National Cancer Institute Common Toxicity Criteria mucositis of grade ≥2 1 Monocytes <200 per µL 1 Stress-induced hyperglycemia 2 a ese factors are integrated into a score ranging from 0–8, which classifies patients into three prognostic classes: low risk (0 points), intermediate risk (1–2 points), and high risk (≥3 points).

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy